BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20/09/2018

FDA Releases Final Guidance on Labeling and Safety Testing for Heparin-Containing Medical Devices

The FDA has released a final guidance document addressing safety concerns related to heparin sodium products following serious and fatal events, outlining new labeling expectations and safety testing recommendations for medical devices and combination products.

Source: Federal Register — Food and Drug AdministrationOpen original release →